JL411. Implementation and Evaluation of an Influenza Adherence Toolkit in Allogeneic Bone Marrow Transplant Recipients
Tracy Krimmel, DNP, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, Susan M. Schneider, PhD, RN, AOCN®, FAAN, Duke University School of Nursing, Durham, NC, Rajat Bannerji, MD, PhD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, and Maribel Borysyuk, PharmD, Walgreens, Dallas, TX
Background: The incidence of influenza in hematopoietic stem cell recipients is 7-35% with a 15-35% mortality rate (Shah et al., 2012). Vinograd et al. (2014) reported a 48% compliance rate in influenza vaccinations. In our NCI-designated cancer center, the baseline adherence rate with influenza vaccination in the post-allogeneic setting was 62.5%. Methods: This project was a pre-test post-test quality improvement project to determine patient knowledge and vaccination adherence rates following implementation of the influenza adherence toolkit. The intervention included: 1) Pre and Post screening survey, 2) The toolkit which includes an influenza disease education pamphlet and financial incentive, and 3) reminder letter. Results: There were 48 eligible patients for the project, 32 completed the pre-screening questionnaire (66.7%). The results showed overall adherence rate for 2015-2016 to be 88.5%, compared to a baseline vaccination rate of 62.5%. Findings also revealed a strong association between provider recommendations and influenza vaccination adherence, 23 of the 24 (96%) patients who had a provider recommend receiving the flu shot did receive it (p=.009). Conclusion: Findings showed that implementation and evaluation of an influenza toolkit in allogeneic hematopoietic recipients improves adherence rates. Consistent with previous studies, there was a strong association between provider recommendation and obtaining the vaccination.
For access to the full length article, please sign in